These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22267889)

  • 1. Predictors of Medication Adherence in Patients with Rheumatoid Arthritis.
    Salt E; Frazier SK
    Drug Dev Res; 2011 Dec; 72(8):756-763. PubMed ID: 22267889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis.
    Xia Y; Yin R; Fu T; Zhang L; Zhang Q; Guo G; Li L; Gu Z
    Patient Prefer Adherence; 2016; 10():735-42. PubMed ID: 27217726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
    Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
    BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature.
    Salt E; Frazier SK
    Orthop Nurs; 2010; 29(4):260-75. PubMed ID: 20664466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: A cross-sectional study.
    Heidari P; Cross W; Weller C; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Apr; 22(4):555-566. PubMed ID: 30924291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis.
    Lathia U; Ewara EM; Nantel F
    Patient Prefer Adherence; 2017; 11():1133-1142. PubMed ID: 28740368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
    Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
    BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial.
    Pouls BPH; Bekker CL; Gundogan F; Hebing RC; van Onzenoort HA; van de Ven LI; Vonkeman HE; Tieben R; Vriezekolk JE; van Dulmen S; Van den Bemt B
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36410776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study.
    Huang Y; Agarwal SK; Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Clin Rheumatol; 2024 Jan; 43(1):103-116. PubMed ID: 37540382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
    McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
    J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy.
    Peter ME; Zuckerman AD; DeClercq J; Choi L; James C; Cooper K; Choi J; Nadler M; Tanner SB
    J Manag Care Spec Pharm; 2021 Jul; 27(7):882-890. PubMed ID: 34185565
    [No Abstract]   [Full Text] [Related]  

  • 15. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study.
    Balsa A; García de Yébenes MJ; Carmona L;
    Ann Rheum Dis; 2022 Mar; 81(3):327-334. PubMed ID: 34844924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Web-Based Patient Empowerment to Medication Adherence Program for Patients With Rheumatoid Arthritis: Feasibility Randomized Controlled Trial.
    Lim S; Athilingam P; Lahiri M; Cheung PPM; He HG; Lopez V
    JMIR Form Res; 2023 Nov; 7():e48079. PubMed ID: 37930758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
    Boytsov NN; Bhattacharya R; Saverno K; Dixon L; Abbott PL; Zhang X; Gaich CL; Nair R
    J Manag Care Spec Pharm; 2019 Aug; 25(8):879-887. PubMed ID: 31347977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis.
    Solomon DH; Tonner C; Lu B; Kim SC; Ayanian JZ; Brookhart MA; Katz JN; Yelin E
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1152-8. PubMed ID: 24470443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adherence to biological therapies in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. (Study ADhER-1)].
    Núñez-Rodríguez J; González-Pérez Y; Nebot-Villacampa MJ; Zafra-Morales R; Obaldia-Alaña MC; Caso-González A
    Semergen; 2021 Mar; 47(2):81-90. PubMed ID: 32778364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.
    Ahluwalia V; Rampakakis E; Movahedi M; Cesta A; Li X; Sampalis JS; Bombardier C
    Clin Rheumatol; 2017 Nov; 36(11):2421-2430. PubMed ID: 28879413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.